• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Science news  
Title Created Date
Cancer research: Are the drugs we count on based on bad science? 27 October 2013
How effective is chemo therapy? 07 October 2013
Long-term side-effects. Molecularly targeted therapies hold promise for many pediatric cancers, but at what cost? 19 July 2013
Are we treating cancer, but killing the patient? 06 April 2013
Radiation generates cancer stem cells from less aggressive breast cancer cells! 22 February 2013
Melatonin's role in cancer 17 January 2013
Chemo can backfire, make cancer worse! 12 December 2012
Display # 

Search

Follow us...

Latest

  • Prediagnostic circulating 25-hydroxyvitamin D and prostate cancer-specific survival: a collaborative pooled analysis of 13 prospective studies
  • Potentially Clinically Beneficial Interactions Between Biologically-Based Complementary Medicines and Cancer Treatment: A Systematic Scoping Review
  • Design, Characterization, and In-Vitro Targeted Delivery of Melatonin via pH-Responsive Niosome Nanoparticles Decorated with Folate Against Colon Cancer Cells
  • Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma
  • Low expression of SGPL1 promotes HCC progression by modulating LacCer metabolism via the S1P-STAT3-B4GALT6 axis
  • Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
  • The profile of melatonin production in tumour-bearing rats
  • Preinduction Serum Vitamin D3 Levels and Induction Chemotherapy Remission Rates in Patients with Acute Leukemia
  • The Effects of Melatonin Administration on Intestinal Injury Caused by Abdominal Irradiation from Mice
  • Association between preoperative vitamin D level and postoperative pain in patients undergoing breast cancer surgery: a prospective observational study
  • Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin
  • TARGETING TUMOR ASSOCIATED MACROPHAGES (TAMS) FOR CANCER TREATMENT: EXPLOITING MELATONIN AS BIOLOGICAL RESPONSE MODIFIER (BRM)
  • SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
  • PROMISING COMPOUNDS WITH HEALTH BENEFITS: PHYTOMELATONIN AND MELATONIN
  • Understanding the role of melatonin in cancer metabolism
  • Melatonin: an essential factor for the treatment and recovery from leukemia and cancer
  • Radioprotective effects of melatonin on radiation-induced cataract
  • Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer